VVOS SEC Filings: 8-K, 10-Q, S-3 & 424B

Financials

TYPE

HEADLINE

FILED AT

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 14, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 20, 2026

NT 10-Q

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

May 15, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Apr 15, 2026

NT 10-K

Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405

Mar 31, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 19, 2025

News

TYPE

HEADLINE

FILED AT

Prospectus

TYPE

HEADLINE

FILED AT

424B3

SHARE RESALE REGISTRATION | Shares: 3,964,712

May 8, 2026

424B3

SHARE RESALE REGISTRATION | Shares: 1,982,356

Jan 14, 2026

424B5

October 2025 ATM | Offering amount: $3,583,686 | Amount sold to date: $8,105,774 | Float: 7,477,266

Oct 24, 2025

424B5

September 2025 ATM | Offering amount: $5,830,572 | Amount sold to date: $7,796,008 | Float: 5,881,977

Sep 12, 2025

424B5

ATM | Offering amount: $3,328,881 | Amount sold to date: $7,796,009 | Float: 5,609,188

Feb 14, 2025

424B1

Form 424B1 - Prospectus [Rule 424(b)(1)]

Jan 31, 2025

Registrations

TYPE

HEADLINE

FILED AT

S-3/A

SHARE RESALE REGISTRATION

Apr 29, 2026

S-3

SHARE RESALE REGISTRATION

Feb 13, 2026

POS AM

Form POS AM - Post-Effective amendments for registration statement

Jan 2, 2026

S-3/A

SHARE RESALE REGISTRATION | Offering amount: $50,000,000 | Float: 5,881,977 | Amount sold to date: $7,796,009

Sep 5, 2025

S-3

Form S-3 - Registration statement under Securities Act of 1933

Feb 11, 2025

S-1/A

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

Jan 29, 2025

Proxies

TYPE

HEADLINE

FILED AT

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Nov 2, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

Oct 29, 2026

PRER14A

Form PRER14A - Preliminary Proxy Soliciting materials

Oct 21, 2026

PRE 14A

Form PRE 14A - Other preliminary proxy statements

Oct 19, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

Sep 26, 2025

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Nov 6, 2024

Ownerships

TYPE

HEADLINE

FILED AT

Krammer Anja B (Reporting)

Oct 27, 2026

Lindsay Mark F. (Reporting)

Oct 26, 2026

Green Ralph Elias (Reporting)

Oct 26, 2026

SOKOLOW LEONARD J (Reporting)

Sep 18, 2026

JOHNSON GREGG C (Reporting)

Sep 18, 2026

Huntsman Ronald Kirk (Reporting)

Sep 18, 2026

Other

TYPE

HEADLINE

FILED AT

EFFECT

Form EFFECT - Notice of Effectiveness

May 11, 2026

CORRESP

Form CORRESP - Correspondence

May 6, 2026

LETTER

Form UPLOAD - SEC-generated letter

Feb 23, 2026

EFFECT

Form EFFECT - Notice of Effectiveness

Jan 8, 2026

EFFECT

Form EFFECT - Notice of Effectiveness

Sep 11, 2025

CORRESP

Form CORRESP - Correspondence

Sep 8, 2025

Vivos Therapeutics, Inc. VVOS · SEC Filings